thromboxanes has been researched along with Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DiMartino, MJ; Egan, JW; Griswold, DE; Hillegass, LM; Smith, EF | 1 |
| Christakis, GT; Henderson, MJ; Ivanov, J; Johnston, LG; Madonik, MM; Mee, AV; Mullen, JC; Teoh, KH; Warbick-Cerone, A; Weisel, RD | 1 |
1 trial(s) available for thromboxanes and Cardiomyopathies
| Article | Year |
|---|---|
Prevention of myocardial platelet deposition and thromboxane release with dipyridamole.
Topics: Arteries; Blood Platelets; Cardiomyopathies; Cell Count; Coronary Circulation; Dipyridamole; Humans; Leukocytes; Myocardium; Prospective Studies; Prostaglandins; Random Allocation; Thromboxanes | 1986 |
1 other study(ies) available for thromboxanes and Cardiomyopathies
| Article | Year |
|---|---|
Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cardiomyopathies; Creatine Kinase; Hemodynamics; Male; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Peroxidase; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxanes | 1989 |